UnitedHealth Group Incorporated (NYSE:UNH - Free Report) - Equities researchers at Leerink Partnrs cut their Q1 2026 earnings per share estimates for shares of UnitedHealth Group in a report issued on Tuesday, May 13th. Leerink Partnrs analyst W. Mayo now expects that the healthcare conglomerate will earn $7.70 per share for the quarter, down from their prior estimate of $8.32. The consensus estimate for UnitedHealth Group's current full-year earnings is $29.54 per share.
Several other equities analysts also recently issued reports on the stock. Argus downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Mizuho raised their price objective on UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Robert W. Baird decreased their price objective on UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating for the company in a research note on Wednesday. JPMorgan Chase & Co. reduced their price objective on UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a research note on Thursday. Finally, Oppenheimer dropped their price objective on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday. Six investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $508.38.
Check Out Our Latest Report on UNH
UnitedHealth Group Trading Down 14.7%
Shares of UNH opened at $262.79 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group has a fifty-two week low of $283.20 and a fifty-two week high of $630.73. The stock has a market capitalization of $238.39 billion, a PE ratio of 17.32, a P/E/G ratio of 1.37 and a beta of 0.56. The company's fifty day moving average is $478.83 and its 200 day moving average is $517.83.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the prior year, the company posted $6.91 earnings per share.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 3.20%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 35.18%.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the business. GKV Capital Management Co. Inc. increased its holdings in shares of UnitedHealth Group by 181.5% in the 1st quarter. GKV Capital Management Co. Inc. now owns 4,110 shares of the healthcare conglomerate's stock worth $2,153,000 after buying an additional 2,650 shares during the last quarter. Parnassus Investments LLC grew its stake in shares of UnitedHealth Group by 4.6% during the first quarter. Parnassus Investments LLC now owns 220,796 shares of the healthcare conglomerate's stock worth $115,642,000 after acquiring an additional 9,617 shares during the last quarter. WPG Advisers LLC acquired a new stake in UnitedHealth Group during the 1st quarter worth about $432,000. Tema Etfs LLC acquired a new position in UnitedHealth Group during the first quarter valued at $3,659,000. Finally, Gerber Kawasaki Wealth & Investment Management increased its holdings in shares of UnitedHealth Group by 7.0% during the 1st quarter. Gerber Kawasaki Wealth & Investment Management now owns 1,258 shares of the healthcare conglomerate's stock valued at $659,000 after purchasing an additional 82 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.
UnitedHealth Group Company Profile
(
Get Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.